泰格医药(03347.HK)遭兴证全球基金减持93.59万股

Summary of Key Points Core Viewpoint - On November 17, 2025, CICC Global Fund Management Co., Ltd. reduced its stake in Tigermed (03347.HK) by selling 935,900 shares at an average price of HKD 41.5596 per share, totaling approximately HKD 38.8956 million. Following this transaction, CICC's holdings decreased from 6.23% to 5.47% of the total shares outstanding [1]. Group 1 - CICC Global Fund Management Co., Ltd. sold 935,900 shares of Tigermed at an average price of HKD 41.5596 per share [1]. - The total value of the shares sold by CICC was approximately HKD 38.8956 million [1]. - After the sale, CICC's total holdings in Tigermed were reduced to 6.7396 million shares, representing 5.47% of the total shares outstanding [1].